Silver Set to Outpe...
Health Care: Drugs
Seattle Genetics Inc. (SGEN: NASDAQ)
$18.98 -0.03 | -0.16%
02/09/12 - 02:30 PM ET
659.21K / 1.70M
Vol / Avg. Vol:19.00 / 19.01
Open / Prev. Close:18.72 - 19.12
Today's Range:12.29 - 22.40
52 Wk Range:13.73%
Performance YTD:TheStreet Rating:
Portfolios with SGEN
- Portfolio NameUser Type
- Contributor10 Biotech Stocks Loved and...
- ContributorEarnings Short Squeeze Play...
- Contributor10 Most Shorted Stocks in B...
- UserBill's 51
- ContributorBreakout Stocks Of The Week...
- Contributor11 Biotech Stocks Loved or ...
- Contributor10 Biotech Trades for Secon...
- Contributor5 mid-cap acquisition targets
- Userjalb7209 Portfolio 1
- ContributorBarron's Insider Purchases ...
Latest SGEN Headlines from TheStreet
- The Next Big Thing In Biotech: 2012 Outlook
01.06.12 | 05:01 am - Dendreon: Provenge Q4 Sales Beat 01.05.12 | 10:01 am
- Seattle Genetics Inc. (SGEN): Today's Featured Drugs Loser 12.15.11 | 04:12 pm
- Seattle Genetics Inc. (SGEN): Today's Featured Health Care Winner 12.08.11 | 04:12 pm
- Biotech Stock Mailbag: Affymax 12.02.11 | 06:12 am
- 10 Biotech Stocks Loved and Hated by Wall Street's Top Investment Pros 11.15.11 | 06:11 am
- Seattle Stock Gaps Down On Today's Open (SGEN) 11.04.11 | 09:11 am
- 10 Most Shorted Stocks in Biotech 10.04.11 | 09:10 am
- 5 Stocks With Relative Strength Poised to Break Out 09.30.11 | 02:09 pm
- When 'Accelerated' FDA Reviews Are Slow 09.27.11 | 11:09 am
Press Releases for SGEN
- Seattle Genetics To Present At Upcoming Investor Conference - Business Wire 02.08.12 | 09:02 am
- Seattle Genetics To Host Conference Call And Webcast Discussion Of Fourth Quarter And Year 2011 Financial Results On February 13, 2012 - Business Wire 02.01.12 | 09:02 am
- Seattle Genetics Announces Data From ADCETRIS™ In Cutaneous T-Cell Lymphoma And Peripheral T-Cell Lymphoma - Business Wire 01.26.12 | 04:01 pm
- Www.millennium.com - Business Wire 01.26.12 | 04:01 pm
- Seattle Genetics Announces Updates To ADCETRIS™ Prescribing Information - Business Wire 01.13.12 | 06:01 am
- Seattle Genetics To Present At The J.P. Morgan Healthcare Conference - Business Wire 01.04.12 | 09:01 am
- Www.millennium.com (Graphic: Business Wire) - Business Wire 12.13.11 | 10:12 am
- Www.takeda.com (Graphic: Business Wire) - Business Wire 12.12.11 | 01:12 pm
- Seattle Genetics Reports Data From Multiple Presentations On ADCETRIS™ (Brentuximab Vedotin) At ASH Annual Meeting - Business Wire 12.12.11 | 01:12 pm
- Seattle Genetics To Present At Upcoming Investor Conference - Business Wire 12.07.11 | 09:12 am
Partner Headlines for SGEN
- Biotech Stocks To Watch In 2012 - Seeking Alpha 02.06.12 | 09:02 am
- 5 Biotech Stocks That Could Double - Seeking Alpha 02.01.12 | 07:02 am
- Biotech Investors Buoyed By Signs Of Speedier Drug Launches - Seeking Alpha 01.09.12 | 08:01 am
- 12 Highly Shorted Stocks Being Snapped Up By Insiders - Seeking Alpha 12.23.11 | 08:12 am
- Seattle Genetics and Millennium Highlight Pivotal Data on ADCETRIS in Relapsed or Refractory Systemic ALCL at ASH Annual Meeting - Benzinga 12.12.11 | 01:12 pm
- Incyte JAK Inhibitor Awaits Certain Approval - Seeking Alpha 11.14.11 | 09:11 am
- Healthcare Sector: Noteworthy Insider Buys And Sells - Seeking Alpha 11.08.11 | 09:11 am
- Top Movers; MedAssets up 17% - Benzinga 11.04.11 | 04:11 pm
- 3 Biotech Takeover/LBO Targets With Bullish Short Trends - Seeking Alpha 10.26.11 | 09:10 am
- Strong Insider Selling: A Signal For Investors To Sell As Well? - Seeking Alpha 10.11.11 | 09:10 am
